Seamus Logan MP: written questions
Seamus Logan MP: full overview
4 Jul 2026–22 Nov 2026 · year in progress
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 3: 4 Jul 2026 to 22 Nov 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
19 published records · newest first.
Written questions
Question text excerpt: To ask the Secretary of State for Health and Social Care, whether her Department plans to establish a national endometriosis clinical network in England comparable to Scotland's National Menstrual Health Specialist… · UIN 44821Department of Health and Social CareTabled 18 Nov 2026Awaiting answerUIN 44821More
Question: To ask the Secretary of State for Health and Social Care, whether her Department plans to establish a national endometriosis clinical network in England comparable to Scotland's National Menstrual Health Specialist Network.
Answer: No published answer in this record yet.
Original Parliament recordQuestion text excerpt: To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure timely access to specialist endometriosis services in England. · UIN 44820Department of Health and Social CareTabled 18 Nov 2026Awaiting answerUIN 44820More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure timely access to specialist endometriosis services in England.
Answer: No published answer in this record yet.
Original Parliament recordQuestion text excerpt: To ask the Secretary of State for Health and Social Care, whether she has considered introducing an NHS England-wide endometriosis pathway similar to that operating across NHS Scotland. · UIN 44819Department of Health and Social CareTabled 18 Nov 2026Awaiting answerUIN 44819More
Question: To ask the Secretary of State for Health and Social Care, whether she has considered introducing an NHS England-wide endometriosis pathway similar to that operating across NHS Scotland.
Answer: No published answer in this record yet.
Original Parliament recordQuestion text excerpt: To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential implications for her policies of the inclusion of a specific commitment to reduce diagnosis times for… · UIN 44818Department of Health and Social CareTabled 18 Nov 2026Awaiting answerUIN 44818More
Question: To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential implications for her policies of the inclusion of a specific commitment to reduce diagnosis times for endometriosis in Scotland's Women's He
Answer: No published answer in this record yet.
Original Parliament recordSteroid Drugs: Accident and Emergency DepartmentsDepartment of Health and Social CareTabled 10 Nov 2026Awaiting answerUIN 41786More
Question: To ask the Secretary of State for Health and Social Care, what steps her Department is taking with the Scottish Health and Social Care Department to ensure that the NHS Steroid Emergency Card is consistently recognised by A&E staff across the UK.
Answer: No published answer in this record yet.
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41785More
Question: To ask the Secretary of State for Health and Social Care, whether her Department plans to convene NHS England, NHS Scotland, the Medicines and Healthcare products Regulatory Agency, pharmaceutical manufacturers, clinicians, and patient support groups to a
Answer: I refer the Rt Hon. Member and the Hon. Member to the response given on 22 April to Question 126862, and to the response given on 25 June to Question 9822.
Answered 17 Nov 2026
Original Parliament recordRare Cancers: ScotlandDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41781More
Question: To ask the Secretary of State for Health and Social Care, what communication has taken place between the National Institute for Healthcare Research Lead for Rare Cancers and the Scottish Government.
Answer: During the drafting of the Rare Cancers Act 2026, the Department held discussions with the Scottish Government and other partners in the devolved administrations. These discussions informed the bill’s legislative approach and territorial extent.The Nation...
Answered 18 Nov 2026
Original Parliament recordRare Cancers: ScotlandDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41780More
Question: To ask the Secretary of State for Health and Social Care, what communications have taken place between the UK Government and the Scottish Government on potential implications for Scotland from the Rare Cancers Act.
Answer: During the drafting of the Rare Cancers Act 2026, the Department held discussions with the Scottish Government and other partners in the devolved administrations. These discussions informed the bill’s legislative approach and territorial extent.The Nation...
Answered 18 Nov 2026
Original Parliament recordPregnancy: Sodium ValproateDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41298More
Question: To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the proactive pregnancy pharmacovigilance system to ensure that errors made in relation to fetal exposure to sodium valproate are not repeated.
Answer: Proactive pregnancy pharmacovigilance systems are essential for monitoring the safety of medicines that are used during pregnancy. Valproate has had a proactive pregnancy pharmacovigilance system in place since 2018, referred to as the pregnancy preventio...
Answered 20 Nov 2026
Original Parliament recordSoft Drinks: NutritionDepartment of Health and Social CareTabled 27 Oct 2026AnsweredUIN 38668More
Question: To ask the Secretary of State for Health and Social Care, how many soft drink products currently on the UK market would be classified as less healthy under (a) the 2004/5 and (b) the 2018 Nutrient Profiling Model.
Answer: I refer the Hon. Member to the answer provided on 5 June in response to Question 1997.
Answered 2 Nov 2026
Original Parliament recordFruit Juices: NutritionDepartment of Health and Social CareTabled 27 Oct 2026AnsweredUIN 38667More
Question: To ask the Secretary of State for Health and Social Care, what the basis is for classifying 100% fruit juice as less healthy under the 2018 Nutrient Profiling Model.
Answer: I refer the Hon. Member to the answer provided on 5 June in response to Question 1997.
Answered 2 Nov 2026
Original Parliament recordNHS: PalantirDepartment of Health and Social CareTabled 23 Oct 2026AnsweredUIN 37561More
Question: To ask the Secretary of State for Health and Social Care, whether her Department has undertaken (a) a fit and proper and (b) other test of the suitability of Palantir as a partner for the Federated Data Platform.
Answer: I refer the Hon. Member to the answers provided on 21 September in response to Question 24886, and on 18 March in response to Question HL14182.
Answered 2 Nov 2026
Original Parliament recordNHS: PalantirDepartment of Health and Social CareTabled 23 Oct 2026AnsweredUIN 37560More
Question: To ask the Secretary of State for Health and Social Care, whether there is a review process regarding Palantir’s role in delivering the Federated Data Platform.
Answer: I refer the Hon. Member to the answers provided on 21 September in response to Question 24886, and on 18 March in response to Question HL14182.
Answered 2 Nov 2026
Original Parliament recordDrugs: PricesDepartment of Health and Social CareTabled 14 Oct 2026AnsweredUIN 34640More
Question: To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the UK-US Pharmaceutical Trade Deal on the Scottish Medicines Consortium's assessments of the cost effectiveness of new medicines.
Answer: The changes to the National Institute for Health and Care Excellence cost-effectiveness threshold and value set which were agreed in the United Kingdom and United States’ pharmaceuticals arrangement do not apply in Scotland, and there is no direct impact ...
Answered 21 Oct 2026
Original Parliament recordOut-patientsDepartment of Health and Social CareTabled 9 Oct 2026AnsweredUIN 33538More
Question: To ask the Secretary of State for Health and Social Care, how many missed outpatient appointments there were in England in each year since 2022.
Answer: Data on missed outpatient appointments is available at the following link:https://digital.nhs.uk/data-and-information/publications/statistical/hospital-outpatient-activityThis refers to instances where a patient did not attend a scheduled appointment.
Answered 15 Oct 2026
Original Parliament recordDepartment of Health and Social Care: ConsultantsDepartment of Health and Social CareTabled 9 Oct 2026AnsweredUIN 33140More
Question: To ask the Secretary of State for Health and Social Care, how much her Department has spent on external consulting since July 2024.
Answer: Expenditure on external consulting is routinely reported in the Department’s annual reports and accounts, which are available at the following link:https://www.gov.uk/government/collections/dhsc-annual-reports-and-accounts
Answered 26 Oct 2026
Original Parliament recordPharmacy: FinanceDepartment of Health and Social CareTabled 9 Oct 2026AnsweredUIN 32709More
Question: To ask the Secretary of State for Health and Social Care, since 2019 how many price concessions were offered to pharmacists who were not able to secure products at the price set out in the NHS list for repaying them, year-on-year.
Answer: The number of price concessions granted to pharmacy contractors in England from 2019 to 2025 is listed in the table below. Figures for the current year will follow in due course.YearNumber of price concessions granted20197462020641202154620221496202317962...
Answered 21 Oct 2026
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 9 Oct 2026AnsweredUIN 31519More
Question: To ask the Secretary of State for Health and Social Care, what discussions she has had with his Scottish counterpart on the potential impact of the UK-US Pharmaceutical Trade Deal on Scotland’s health budget in each of the next five years.
Answer: No such discussion has taken place. Engagement on the impact of the United Kingdom and United States’ Pharmaceuticals arrangement continues at official level as appropriate.
Answered 26 Oct 2026
Original Parliament recordTrade Agreements: USADepartment of Health and Social CareTabled 9 Oct 2026AnsweredUIN 30691More
Question: To ask the Secretary of State for Health and Social Care, if she will publish impact assessments, modelling and further detail on the UK-US pharmaceutical trade deal.
Answer: I refer the Hon Member to the answer he received on 20 January in response to Question 106237.
Answered 19 Oct 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2026–22 Nov 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →